Table 2: Registration of clinical trials with stem cells in the UAE COVID-19 National Research Registry, 2021.
Ref. No. |
Title |
Status |
Sponsor |
Administration route* / Product |
Diseases / Conditions |
27 |
Intra-Vein Injection of allogeneic mesenchymal stem cells for support of COVID-19 patients |
Pending |
King’s College Hospital London, UAE |
IV / Mesenchymal Stem Cells |
COVID-19 patients |
52 |
Phase 3 Clinical Trial for the usage of mesenchymal stem cells (MSC) and high doses of vitamin C to treat COVID 19 patients at Dubai Health Authority |
Completed |
Dubai Cord Blood & Research Center, UAE |
IV / Mesenchymal Stem Cells |
Severe COVID-19 patients |
7 |
Usage of stem cells to treat coronavirus disease 2019 (COVID-19) patients |
Not-approved |
Dubai Cord Blood & Research Center, UAE |
Not specified |
COVID-19 patients |
1 |
Clinical Efficacy of Autologous Stromal Vascular Fraction (SVF) for Acute COVID-19 Infection |
Not-approved |
Cell Surgical Network, US |
Not specified / Stromal Vascular Fraction (SVF) |
COVID-19 patients |
Source: UAE COVID-19 Research Registry platform [11].
*IV: Intravenous.